Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
3,172,831
-
Total 13F shares
-
173,850
-
Share change
-
+173,401
-
Total reported value
-
$587,905
-
Price per share
-
$3.39
-
Number of holders
-
16
-
Value change
-
+$586,622
-
Number of buys
-
14
Institutional Holders of 180 Life Sciences Corp. - Common Stock, $0.0001 par value (ATNF) as of Q4 2022
As of 31 Dec 2022,
180 Life Sciences Corp. - Common Stock, $0.0001 par value (ATNF) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
173,850 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, and Cutler Group LLC / CA.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.